Combinations of pyrazole kinase inhibitors and further antitumor agents

Details for Australian Patent Application No. 2006207322 (hide)

Owner Astex Therapeutics Limited

Inventors Thompson, Kyla Merriom; Lyons, John Francis; Wyatt, Paul Graham; Squires, Matthew Simon; Thompson, Neil Thomas; Curry, Jayne Elizabeth

Agent Davies Collison Cave

Pub. Number AU-A-2006207322

PCT Pub. Number WO2006/077425

Priority 60/645,963 21.01.05 US

Filing date 20 January 2006

Wipo publication date 27 July 2006

International Classifications

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/00 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/077425 Priority application(s): WO2006/077425

18 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207323-4- (2, 6-dichlorobenzoylamino) - lH-pyrazole-3 -carboxylic acid piperidin4 -ylamid acid addition salts as kinase inhibitors

2006207321-Pharmaceutical compounds